» Articles » PMID: 20654663

Retinoid Pathway and Cancer Therapeutics

Overview
Specialty Pharmacology
Date 2010 Jul 27
PMID 20654663
Citations 151
Authors
Affiliations
Soon will be listed here.
Abstract

The retinoids are a class of compounds that are structurally related to vitamin A. Retinoic acid, which is the active metabolite of retinol, regulates a wide range of biological processes including development, differentiation, proliferation, and apoptosis. Retinoids exert their effects through a variety of binding proteins including cellular retinol-binding protein (CRBP), retinol-binding proteins (RBP), cellular retinoic acid-binding protein (CRABP), and nuclear receptors i.e. retinoic acid receptor (RAR) and retinoid x receptor (RXR). Because of the pleiotropic effects of retinoids, understanding the function of these binding proteins and nuclear receptors assists us in developing compounds that have specific effects. This review summarizes our current understanding of how retinoids are processed and act with an emphasis on the application of retinoids in cancer treatment and prevention.

Citing Articles

AEGAN-Pathifier: a data augmentation method to improve cancer classification for imbalanced gene expression data.

Zhang Q, Wei Y, Hou J, Li H, Zhong Z BMC Bioinformatics. 2024; 25(1):392.

PMID: 39731019 PMC: 11673641. DOI: 10.1186/s12859-024-06013-z.


Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells.

Howard J, Levinger C, Deletsu S, Fromentin R, Chomont N, Bosque A PLoS Pathog. 2024; 20(10):e1012601.

PMID: 39401241 PMC: 11501018. DOI: 10.1371/journal.ppat.1012601.


Roles of the NR2F Family in the Development, Disease, and Cancer of the Lung.

Yang J, Sun W, Cui G J Dev Biol. 2024; 12(3).

PMID: 39311119 PMC: 11417824. DOI: 10.3390/jdb12030024.


Multidimensional role of adapalene in regulating cell death in multiple myeloma.

Cao X, Xiang J, Zhang Q, Liu J, Zhou D, Xu Y Front Pharmacol. 2024; 15:1415224.

PMID: 39175546 PMC: 11338798. DOI: 10.3389/fphar.2024.1415224.


Tretinoin synergistically enhances the antitumor effect of combined BRAF, MEK, and EGFR inhibition in BRAF colorectal cancer.

Yoshida Y, Takahashi M, Taniguchi S, Numakura R, Komine K, Ishioka C Cancer Sci. 2024; 115(11):3740-3754.

PMID: 39175203 PMC: 11531965. DOI: 10.1111/cas.16280.


References
1.
Van Herle A, Agatep M, Padua 3rd D, Totanes T, Canlapan D, Van Herle H . Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells (UCLA R0 82 W-1) in vitro. J Clin Endocrinol Metab. 1990; 71(3):755-63. DOI: 10.1210/jcem-71-3-755. View

2.
Xu X, Ro J, Lee J, Shin D, Hong W, Lotan R . Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res. 1994; 54(13):3580-7. View

3.
Chengedza S, Benbrook D . NF-kappaB is involved in SHetA2 circumvention of TNF-alpha resistance, but not induction of intrinsic apoptosis. Anticancer Drugs. 2009; 21(3):297-305. PMC: 2902153. DOI: 10.1097/CAD.0b013e3283350e43. View

4.
Lippman S, Sudbo J, Hong W . Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol. 2005; 23(2):346-56. DOI: 10.1200/JCO.2005.09.128. View

5.
Geiger J, HOMMEL L, Harms M, Saurat J . Oral 13-cis retinoic acid is superior to 9-cis retinoic acid in sebosuppression in human beings. J Am Acad Dermatol. 1996; 34(3):513-5. DOI: 10.1016/s0190-9622(96)90462-4. View